Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionik Laboratories Corp BNKL

Bionik Laboratories Corp. is a robotics company, which provides neurological functional recovery solutions to stroke survivors and others with neurological and mobility challenges. It uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and deliver recovery for patients with neurological or mobility impairments. It has a portfolio... see more

Recent & Breaking News (GREY:BNKL)

Bionik Laboratories Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations

Business Wire June 15, 2023

Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida

Business Wire May 23, 2023

Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong

Business Wire May 4, 2023

Bionik Laboratories' InMotion® Robotic Devices on Display at the Korea International Medical & Hospital Equipment Show (KIMES)

Business Wire March 23, 2023

Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results

Business Wire February 8, 2023

Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results

Business Wire November 9, 2022

Bionik Laboratories to Present at the Q4 Virtual Investor Summit

GlobeNewswire November 7, 2022

Bionik Laboratories Appoints Richard Russo, Jr. as Chief Executive Officer and Dan Gonsalves as Chief Financial Officer

Business Wire October 13, 2022

Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout

Business Wire September 8, 2022

BIONIK Laboratories to Present at National Investment Banking Association Conference

Accesswire September 1, 2022

BIONIK Laboratories Reports First Quarter Financial Results

Business Wire August 10, 2022

BIONIK Laboratories Corp. to Present at Investor Summit Group's Q3 Virtual Conference

Business Wire August 9, 2022

BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center

Business Wire June 23, 2022

BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Business Wire June 9, 2022

BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors

Newsfile May 25, 2022

BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo

Business Wire March 30, 2022

BIONIK Laboratories Reports 15-20% Increase in Therapeutic Gains on InMotion® Robotic Devices in New Patient Outcomes Data Report

Business Wire March 29, 2022

BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results

Business Wire February 9, 2022

BIONIK Laboratories to Participate at the American Physical Therapy Association Conference

Business Wire January 31, 2022

BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry

Business Wire November 11, 2021